首页 | 本学科首页   官方微博 | 高级检索  
检索        


Longitudinal impact of temporary mechanical circulatory support on durable ventricular assist device outcomes: An IMACS registry propensity matched analysis
Institution:1. Cleveland Clinic Florida, Section Heart Failure and Cardiac Transplant Medicine, Weston, Florida;2. University of Alabama at Birmingham, Birmingham, Alabama;3. Division of Cardiology, Masschusetts General Hospital, Boston, Massachusetts;4. Gasthuisberg University Hospital, Leuven, Belgium;5. National Cardiovascular Center, Osaka, Japan;6. National Cerebral and Cardiovascular Center, Osaka, Japan;7. Royal Papworth Hospital, Cambridge, United Kingdom;8. Wythenshawe Hospital, Manchester, United Kingdom;9. KEM - Institute for Clinical and Experimental Medicine, Prague, Czech Republic;10. Montefiore Medical Center, New York, New York;11. Henry Ford Health System, Detroit, Michigan;1. Duke Clinical Research Institute, Durham, NC;2. Mercy Health, Chesterfield, MO;3. University of Washington, Seattle, WA;4. Herbert and Sandi Feinberg Interventional Cardiology and Heart Valve Center at Columbia University Medical Center/New York–Presbyterian Hospital and Cardiovascular Research Foundation, New York, NY;5. US Food Drug Administration, Silver Spring, MD;6. European Cardiovascular Research Center, Massy, France;7. Weill Cornell Medical College, New York, NY;8. Boston Scientific, St Paul, MN;1. Clinical Research and Evaluation Unit, West China Hospital, Sichuan University, Chengdu, China;2. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China;3. Department of Science and Technology, West China Hospital, Sichuan University, Chengdu, China;4. Institute of Biomedical Engineering, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, China;1. Section of Heart Failure, Cardiac Transplant, and Mechanical Circulatory Support, and Department of Medicine, Stanford University, Stanford, California, USA;2. Division of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada;1. Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut;2. Department of Cardiovascular Medicine and Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota;3. Section of Cardiac Surgery, Yale University School of Medicine, New Haven, Connecticut;4. Center for Outcomes Research & Evaluation (CORE), Yale University School of Medicine, New Haven, Connecticut;5. Yale National Clinician Scholars Program, Yale University School of Medicine, New Haven, Connecticut;1. Department of Cardiology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden;2. Department of Medical Sciences, Uppsala University, Uppsala, Sweden;3. Department of Cardiology, Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号